Back to the main directory
Press Release
- DGAP-News: Varengold Bank AG steigert im ersten Halbjahr 2022 Kennzahlen deutlich by EQS Group AG
- BrainsWay to Report Second Quarter Financial Results on August 10, 2022 by GlobeNewsWire
- INmune Bio, Inc. to Report Second Quarter 2022 Financial Results and Provide a Corporate Update on Wednesday, August 3 by GlobeNewsWire
- Freshworks Helps Businesses Deliver More Delightful Customer Experiences with a New Integration with Google’s Business Messages by GlobeNewsWire
- Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as Chief Executive Officer and Board Member by GlobeNewsWire
- Vaxart Provides New Update on Proxy Voting and Urges All Stockholders of Record as of April 11, 2022, to Vote by August 3, 2022, at 11:59 p.m. ET by GlobeNewsWire
- Sensus Healthcare Takes Order for 10 TransDermal Infusion Systems™ Supporting Hair Enhancement Centers Expansion Along with U.SK Under Skin’s Hair-Health Serum by GlobeNewsWire
- Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S. by GlobeNewsWire
- AcuityAds Announces Date for Second Quarter 2022 Financial Results Video Conference Call by GlobeNewsWire
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement by GlobeNewsWire
- Neoleukin Therapeutics to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 9, 2022 by GlobeNewsWire
- Aqua Metals Appoints Dave McMurtry as Chief Business Officer by GlobeNewsWire
- Atmosphere Selects SpringServe to Power Programmatic Advertising for Digital Out of Home Campaigns by GlobeNewsWire
- Mayfair Gold Drills 1.40 g/t Gold over 65.0m from Fenn-Gib Expansion Drill Program by GlobeNewsWire
- Asia Broadband Reintroduces Convert Feature Within the AABB Wallet to Purchase AABBG Gold-Backed Tokens by GlobeNewsWire
- Lexicon Announces FDA Acceptance of New Drug Application for Sotagliflozin to Treat Heart Failure by GlobeNewsWire
- AeroClean Deploys Safe Air Technology at Notable Hospitality & Club Spaces through Partnership with the Florida Chapter of the Club Management Association of America (FLCMAA) by GlobeNewsWire
- MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts by GlobeNewsWire
- Akoya to Participate at Two Upcoming Investor Conferences by GlobeNewsWire
- Palisade Bio Announces First Patient Screened in Phase 3 Study Evaluating LB1148 for Postoperative Return of Bowel Function by GlobeNewsWire
- Startek Sets Second Quarter 2022 Conference Call for Monday, August 8, 2022 at 5 p.m. ET by BusinessWire
- Amphenol Reports Second Quarter 2022 Record Results by BusinessWire
- Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 by BusinessWire
- Fifth Third Launches Empowering Community Leaders Nonprofit Capacity Building Program by BusinessWire
- Finance Calender 2022-23 by GlobeNewsWire
- BOK Financial Corporation Reports Quarterly Earnings of $133 million or $1.96 Per Share in the Second Quarter by GlobeNewsWire
- Landec Corporation Sets Fourth Quarter 2022 Earnings Conference Call for August 10, 2022 at 2:00 p.m. PT by GlobeNewsWire
- iCAD to Report Second Quarter 2022 Financial Results on August 10, 2022 by GlobeNewsWire
- Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022 by GlobeNewsWire
- LifeMD, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 11, 2022 by GlobeNewsWire
- CPI Aerostructures Receives $3.2 Million Order From Boeing Under A-10 ATTACK Re-Wing Contract by GlobeNewsWire
- Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia by GlobeNewsWire
- SigmaTron International, Inc. Reports Year End Financial Results for Fiscal 2022 by GlobeNewsWire
- Intercept to Announce Second Quarter 2022 Financial Results on August 3, 2022 by GlobeNewsWire
- Progyny is First Fertility Benefits Solution to Publish Outcomes with Independent Validation by GlobeNewsWire
- Mustang Bio Announces First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy to Treat RAG1 Severe Combined Immunodeficiency by GlobeNewsWire
- HomeTrust Bancshares, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Quarterly Dividend by GlobeNewsWire
- LexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections by GlobeNewsWire
- Grom Social Enterprises Chief Executive Officer Delivers Annual Review and Update Letter to Shareholders by GlobeNewsWire
- Celularity Announces Treatment of First Patient in Phase 1/2a Clinical Trial for NK Cell Therapy CYNK-101, in Development for the First-Line Treatment of Advanced HER2 Positive Gastric and Gastroesophageal Junction (G/GEJ) Cancers by GlobeNewsWire
- Medicenna Announces New Clinical Data Providing Preliminary Evidence of MDNA11’s Single Agent Anti-Cancer Activity in the Phase 1/2 ABILITY Study by GlobeNewsWire
- Cidara Therapeutics Submits NDA for Rezafungin and Announces License Agreement with Melinta Therapeutics for Commercialization of Rezafungin in the U.S. by GlobeNewsWire
- Nuvectis Pharma, Inc. Announces Approximately $15.9 Million Private Placement by GlobeNewsWire
- TRACON to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 10, 2022 by GlobeNewsWire
- Farmers National Banc Corp. Reports 2022 Second Quarter Results by BusinessWire
- Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program by BusinessWire
- Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 by BusinessWire
- Keysight Technologies to Host Webcast of Third Quarter Fiscal Year 2022 Earnings Conference Call by BusinessWire
- LIZHI Deepens Huawei HarmonyOS Partnership Through Launch on AITO Smart Vehicles by GlobeNewsWire
- Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine by GlobeNewsWire